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Kraft and Stram2 should be viewed with great caution.
First, the maximum-likelihood method implemented in
their simulation study pertains to the prospective likeli-
hood, which ignores the case-control sampling. Second,
the inclusion of haplotypes with very low frequencies can
cause numerical instabilities. Third, the setup of 32 hap-
lotypes with equal frequencies is highly unrealistic.
Imputation can be a good approximation of maximum
likelihood in many situations but can never be superior.
Given the availability of HAPSTAT and other user-friendly
software, there is no strong reason to not use proper max-
imum likelihood.
D. Y. LIN AND B. E. HUANG
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Impact of Array Comparative Genomic
Hybridization–Derived Information on Genetic
Counseling Demonstrated by Prenatal
Diagnosis of the TAR (Thrombocytopenia-
Absent-Radius) Syndrome–Associated
Microdeletion 1q21.1
To the Editor: The latest array-based genome-scanning
methods are beginning to revolutionize clinical genetics.1
Prominent recent examples derived from array technol-
ogies include the identification of new microdeletion syn-
dromes, such as the 17q21.3 microdeletion syndrome
(MIM 610443),2–4 and the elucidation of genomic loci har-
boring genes for CHARGE (MIM 214800)5 and Pitt-Hop-
kins syndrome (MIM 610954).6–8 Furthermore, array ap-
plications revealed a plethora of copy-number variations
(CNVs) in the human genome.9 Some of these CNVs likely
contribute to complex human disorders such as Crohn
disease (MIM 266600)10 and autism.11,12 An especially in-
teresting contribution of array comparative genomic hy-
bridization (array-CGH) has been helping to unravel the
cause of thrombocytopenia-absent-radius syndrome (TAR)
(MIM 274000), a rare syndrome characterized by bilateral
absence of the radii with presence of both thumbs and
thrombocytopenia,13 which was published in the February
2007 issue of the Journal.14 Klopocki et al.14 reported that
TAR syndrome has a complex pattern of inheritance as-
sociated with a common interstitial microdeletion of 200
kb on chromosome 1q21.1 and an additional, as-yet-un-
known modifier. This microdeletion was not present in
700 control samples and has not yet been described in the
Database of Genomic Variants.14
To exemplify how the new knowledge derived from ar-
ray-based analyses extends our ability to improve genetic
counseling, we describe here the prenatal case of a non-
consanguineous couple. The 42-year-old pregnant woman
(G2P0 at the time of counseling) and her 45-year-old hus-
band were referred to our genetic counseling service. Dur-
ing ultrasound examination at a gestational age of 16 wk,
bilateral phocomelia was found. No other abnormalities
were noted at that time, and the hands were not well
visualized. During the woman’s first pregnancy, phoco-
melia had also been noted at a gestational age of 14 wk,
and the pregnancy was terminated at the 22nd gestational
week. At this time, chromosome analysis from amnion
cells revealed a normal female karyotype (46,XX), and no
further analysis had been done. Both parents had an un-
remarkable phenotype.
If phocomelia is diagnosed during prenatal ultrasound
examination, the most important differential diagnoses
include TAR (MIM 274000), Holt-Oram (MIM 142900),
and Roberts syndrome (MIM 268300). In the latter two
conditions, the thumb is usually absent or severely hy-
poplastic. However, hands may not always be well visu-
alized during an ultrasound, and occasionally patients
with Roberts syndrome may exhibit normal thumbs.15
Thus, on the basis of ultrasound examination alone, a
definite diagnosis is impossible. In both TAR and Holt-
Oram syndromes, conventional cytogenetic analysis usu-
ally yields normal karyotypes, whereas ∼80% of cases with
Roberts syndrome exhibit a chromosomal phenomenon
known as “premature centromere separation.”16 There-
fore, conventional chromosome banding analysis is often
inconclusive. As a consequence, cordocentesis is often
considered to evaluate fetal platelet count,17–20 because, in
TAR, platelet counts are often !50 platelets/nl (normal
range 150–400 platelets/nl).21 Although such a fetal plate-
let count is mandatory to establish the diagnosis of TAR
syndrome and to differentiate it from other syndromes
with malformations of the upper limbs, cordocentesis
was reported to have a 1%–2% risk of fetal loss.22 In ad-
dition, thrombocytopenia may not appear before the third
trimester of pregnancy or even until the first months of
life,23 making an early diagnosis based on platelet count
difficult.
To provide accurate genetic counseling, it is essential to
make a correct diagnosis. In this case, we could utilize the
very recent information about inheritance of TAR syn-
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Figure 1. Hybridization patterns of BAC-clone RP11-698N18, which maps into the TAR microdeletion on chromosome band 1q21.1
on metaphase spreads of the mother (A), father (B), and fetus (C). Arrows in panels B and C indicate the derivative chromosome 1
with the microdeletion 1q21.1. A, In addition to BAC-clone RP11-698N18 (red), we hybridized BAC clones 14e10 (chromosome location:
1p36.3) and GS160H20 (1q44) (both green) as controls. In this exemplary metaphase spread, all probes show two signals each on
the two chromosomes 1. Thus, the mother’s karyotype can be described as: 46,XX.ish 1p36.3(14e10x2),1q21.1(RP11-698N18x2),
1q44(GS160H20x2). B, We hybridized the identical probe, set as described above, to the father’s metaphase spreads. In contrast with
our findings for the mother, we observed in all metaphase spreads only one hybridization signal for clone RP11-698N18. The father’s
karyotype is therefore 46,XY.ish 1p36.3(14e10x2),1q21.1(RP11-698N18x1),1q44(GS160H20x2). C, To metaphase spreads of the fetus,
we hybridized, in addition to clone RP11-698N18 (red), only the 1p36 control probe 14e10 (green). There was again only one hybridization
signal for clone RP11-698N18, indicating that the fetus had inherited the 1q21.1 microdeletion from his father. The complete karyotype
of the fetus is 46,XY.ish 1p36.3(14e10x2),1q21.1(RP11-698N18x1).
drome,14 and we offered the couple a prenatal diagnosis
by amniocentesis. Conventional banding analysis showed
a normal male karyotype (46,XY). However, in addition
to conventional karyotyping, we now hybridized BAC-
clone RP11-698N18, which maps into the TAR microde-
letion on chromosome band 1q21.114 onto metaphase
spreads of both parents and of the fetus. We observed two
hybridization signals for the chromosome 1q21.1 clone
on all analyzed metaphase spreads of the mother (fig. 1A),
whereas all metaphase spreads of the father consistently
showed only one signal (fig. 1B). In addition, we detected
this 1q21.1 microdeletion in all metaphase spreads of the
fetus (fig. 1C). The sonographic finding of upper-limb mal-
formations in the fetus, together with the detection of the
1q21.1 microdeletion, allowed us to conclude from the
aforementioned differential diagnoses that TAR syndrome
is most likely. Therefore, we could provide precise genetic
counseling, including a detailed explanation of the spec-
trum of phenotypic features associated with TAR syn-
drome. At a later date, the couple decided to terminate
the pregnancy. Physical examination of the fetus revealed
malformed upper extremities and absence of both radii,
with opposable thumbs in an adducted position. The par-
ents declined further examination, including a platelet
count and a post mortem examination.
Our case nicely confirms the findings described by Klo-
pocki et al.14—namely, identification of the interstitial mi-
crodeletion 1q21.1 in an unaffected parent and detection
of the same microdeletion in an offspring with upper-limb
deformities. As hypothesized elsewhere,14 the TAR phe-
notype apparently develops only in the presence of an
additional, as-yet-unknown modifier. It is likely that this
modifier, in addition to the 1q21.1 microdeletion, was
inherited not only in the current pregnancy but also in
the previous, first pregnancy, which was, according to the
clinical records, also associated with phocomelia.
Our case represents a prime example of the impact of
newly gained, array-based knowledge on both genetic
diagnostics and counseling. At present, utilization of
this knowledge is in its early infancy. However, sys-
tematic collections of CNVs and their association with
specific phenotypes in publicly accessible databases,
such as DECIPHER (Database of Chromosomal Imbalance
and Phenotype in Humans using Ensembl Resources)
will certainly change our options in multiple counseling
scenarios.
SABINE UHRIG, DIETMAR SCHLEMBACH,
JULIE WALDISPUEHL-GEIGL, WERNER SCHAFFER,
JOCHEN GEIGL, EVA KLOPOCKI, STEFAN MUNDLOS,
AND MICHAEL R. SPEICHER
Web Resources
The URLs for data presented herein are as follows:
DECIPHER, http://www.sanger.ac.uk/PostGenomics/decipher/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for 17q21.3 microdeletion syndrome,
CHARGE syndrome, Pitt-Hopkins syndrome, Crohn disease,
TAR syndrome, Holt-Oram syndrome, and Roberts syndrome)
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